For Investors
Why Invest?
RegenMed is an established, revenue-producing company disrupting a + $1 trillion healthcare data market. It enjoys a global client base, strong monthly recurring revenue growth, significant competitive moats, and seasoned leadership. RegenMed considers that it is in a strong position to further accelerate its market capture, and deliver sustained returns to its shareholders.
INVESTMENT THESES
Investor Updates
Disclaimers
This website may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. These forward-looking statements are based on the beliefs of, assumptions made by, and information currently available to the company’s management. when used in the offering materials, the words “estimate,” “project,” “believe,” “anticipate,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements. These statements reflect management’s current views with respect to future events and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. the company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.
Our Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.